Poop pills tested to boost Cancer-Killing cell therapy
NCT ID NCT07042438
Summary
This study is testing whether a fecal microbiome transplant (FMT) can improve the effectiveness of CAR-T cell therapy for patients with hard-to-treat lymphoma. Participants who have taken strong antibiotics will receive either the FMT treatment or a placebo alongside their standard CAR-T therapy. Researchers want to see if restoring healthy gut bacteria helps patients respond better to the cancer treatment and reduces side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.